2026 Efficacy of progestogen therapy for extragenital endometriosis: clinical outcomes and MRI-detected changes in lesion characteristics ·doi:10.18565/aig.2026.204
2025 Characteristics of nutritional status in endometriosis and pain syndrome ·doi:10.18565/aig.2025.131
2024 A profile of autoantibodies to steroid hormones and steroidogenic enzymes in women with endometriosis ·doi:10.18565/aig.2024.253
2024 Features of the profile of serum autoantibodies to reproductive hormones and steroidogenic enzymes in patients with endometriosis-related infertility and infertile patients without endometriosis ·doi:10.18565/aig.2024.296
2023 Comparison of the profile of serum autoantibodies in women with different forms of endometriosis ·doi:10.18565/aig.2023.105
2022 Expression of exosomal microRNA in high-grade ovarian cancer and ovarian endometriotic cysts ·doi:10.18565/aig.2022.3.68-79
2022 Prevalence and importance of autoantibodies for non-invasive diagnostics of external genital endometriosis in women ·doi:10.18565/aig.2022.3.59-67
2021 Steroid hormone profiles in reproductive age patients with advanced endometriosis ·doi:10.18565/aig.2021.3.90-100
2020 The role of bacterial contamination in the development of endometriosis ·doi:10.18565/aig.2020.1.47-53
2019 Features of the profile of proteins secreted by cells from the endometrioid foci and eutopic endometrium in women with external genital endometriosis in vitro culture ·doi:10.18565/aig.2019.8.90-99
2018 Assessment of microRNA expression in retrocervical endometriotic lesions ·doi:10.18565/aig.2018.6.55-61
2017 Use of transcriptomic databases for the analysis of pathogenetic factors of endometriosis ·doi:10.18565/aig.2017.4.34-44
2016 Surgical treatment for infiltrating endometriosis of the urinary tract ·doi:10.18565/aig.2016.4.72-78